FIELD: biotechnology; medicine.
SUBSTANCE: there are presented an agent for treatment and prevention of hyperglycemia and insulin resistance and related diseases and functional disorders of organs and systems, its application and a method of treatment and prevention with its use. Agent contains recombinant human apolipoprotein A-I (rApoA-I-3-243), having the amino acid sequence SEQ ID NO: 1. Functional diseases and disorders of organs and systems associated with hyperglycemia and insulin resistance, are selected from obesity, diabetes mellitus type 2, dysfunctions of liver and kidneys, bone marrow, spleen, myocardium, reproductive system, locomotor activity and cognitive functions. Introduction of said agent to a subject in need thereof in therapeutically effective doses is carried out locally or parenterally.
EFFECT: inventions provide correction of the functional state of a subject suffering from hyperglycemia and insulin resistance, reducing functional disorders of liver, kidneys, bone marrow and spleen, reproductive system organs, improving myocardial contractility, improving locomotor activity and cognitive function in a subject.
42 cl, 9 dwg, 14 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL AGENTS, COMPOSITIONS, AND METHODS RELATED THERETO | 2018 |
|
RU2765286C2 |
METHOD FOR CORRECTION OF ABDOMINAL TYPE OBESITY AND METABOLIC SYNDROME | 2021 |
|
RU2761727C1 |
METHOD FOR CORRECTION OF BLOOD SUGAR LEVEL AND TREATMENT OF PATIENTS WITH TYPE TWO DIABETES MELLITUS AND COGNITIVE DEFECTS | 2011 |
|
RU2467749C1 |
FASTING CONDITION AS DIETARY TREATMENT OF DIABETES | 2014 |
|
RU2672594C2 |
METHOD FOR CREATING TRANSLATIONAL MODEL OF DIABETIC PHENOTYPE OF CHRONIC HEART FAILURE | 2023 |
|
RU2817822C1 |
STATE OF ABSTINENCE FROM FOOD AS A DIETARY TREATMENT OF DIABETES | 2014 |
|
RU2727960C2 |
MATERIALS AND METHOD FOR MODULATION OF PROLIFERATION AND DIFFERENTIATION OF REGULATORY, STEM AND OTHER SOMATIC CELLS | 2014 |
|
RU2620069C2 |
FOOD PRODUCT FOR DIABETICS | 2005 |
|
RU2380983C2 |
METHOD FOR MODELLING NON-ALCOHOLIC FATTY LIVER DISEASE BY DIET RICH IN FRUCTOSE | 2019 |
|
RU2728418C1 |
AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
Authors
Dates
2024-07-22—Published
2023-07-24—Filed